nifekalant

 

Topic mentions per year

Topic mentions per year

2001-2017
0520012017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
OBJECTIVE To compare the efficacy of nifekalant and amiodarone in the treatment of cardiac arrest in a porcine model. METHODS… (More)
Is this relevant?
2010
2010
OBJECTIVE To compare the efficacy and safety of nifekalant, a pure class III anti-arrhythmic drug, and lidocaine in patients with… (More)
  • table 1
  • table 2
  • table 3
  • table 5
Is this relevant?
2010
2010
BACKGROUND In Japan, intravenous nifekalant (NIF) was often used for direct current cardioversion-resistant ventricular… (More)
Is this relevant?
2009
2009
BACKGROUND Intravenous amiodarone (AMD) has been used for the treatment of ventricular tachycardia/fibrillation (VT/VF) in… (More)
Is this relevant?
2007
2007
Nifekalant (NF) is a novel class III antiarrhythmic agent that is effective in preventing life-threatening ventricular… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2006
2006
Class III antiarrhythmic agents have been widely used to suppress ventricular tachyarrhythmias in patients with heart failure… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 4
Is this relevant?
2006
2006
BACKGROUND Although nifekalant is a class III antiarrhythmic agent without negative inotropic activity, its effect in patients… (More)
Is this relevant?
2005
2005
BACKGROUND Because class I anti-arrhythmic drugs sometimes suppress cardiac function caused by their negative inotropic effects… (More)
Is this relevant?
2004
2004
Cardiovascular effects of Nifekalant were examined using halothane-anesthetized dogs, and its proarrhythmic potential was… (More)
Is this relevant?
2002
2002
Nifekalant is a class III antiarrhythmic drug that has been shown to be effective against ventricular tachyarrhythmias in… (More)
Is this relevant?